Results 191 to 200 of about 14,035,857 (361)

ShcD adaptor protein drives invasion of triple negative breast cancer cells by aberrant activation of EGFR signaling

open access: yesMolecular Oncology, EarlyView.
We identified adaptor protein ShcD as upregulated in triple‐negative breast cancer and found its expression to be correlated with reduced patient survival and increased invasion in cell models. Using a proteomic screen, we identified novel ShcD binding partners involved in EGFR signaling pathways.
Hayley R. Lau   +11 more
wiley   +1 more source

Evaluation of patient doses for routine digital radiography procedures toward establishing an institutional diagnostic reference levels: A case study in Sri Lanka

open access: yesJournal of Applied Clinical Medical Physics, Volume 23, Issue 12, December 2022., 2022
Abstract The present study was conducted as part of a comprehensive work to establish National Diagnostic Reference Levels (NDRLs) in Sri Lanka for the first time. DRLs can be used as an effective optimization tool for identifying unusually high or low patient doses during X‐ray examinations.
Sachith Welarathna   +3 more
wiley   +1 more source

Beacon Light: Summer 2002 [PDF]

open access: yes, 2002
Story on the wilderness theme in pediatric care Poster contest winner shares inspiration Dan Whitlock on the nuances of hospital rankings Feature on a successful total knee replacement procedure Upcoming events concerning the Hospital Article on the two ...
St. Cloud Hospital
core   +1 more source

Comparing Federated Stochastic Gradient Descent and Federated Averaging for Predicting Hospital Length of Stay [PDF]

open access: yesarXiv
Predicting hospital length of stay (LOS) reliably is an essential need for efficient resource allocation at hospitals. Traditional predictive modeling tools frequently have difficulty acquiring sufficient and diverse data because healthcare institutions have privacy rules in place. In our study, we modeled this problem as an empirical graph where nodes
arxiv  

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu   +11 more
wiley   +1 more source

Beacon Light: Spring 1999 [PDF]

open access: yes, 1999
Profile on the Doctors qualified to perform advanced procedures in cardiac care Story on the Senior Helping Hands program Opening of The CentraCare Diabetes Center Hospital\u27s Employee Assistant Program (EAP) advertised The various ways the Hospital ...
St. Cloud Hospital
core   +1 more source

Tonic signaling of the B‐cell antigen‐specific receptor is a common functional hallmark in chronic lymphocytic leukemia cell phosphoproteomes at early disease stages

open access: yesMolecular Oncology, EarlyView.
B‐cell chronic lymphocytic leukemia (B‐CLL) and monoclonal B‐cell lymphocytosis (MBL) show altered proteomes and phosphoproteomes, analyzed using mass spectrometry, protein microarrays, and western blotting. Identifying 2970 proteins and 316 phosphoproteins, including 55 novel phosphopeptides, we reveal BCR and NF‐kβ/STAT3 signaling in disease ...
Paula Díez   +17 more
wiley   +1 more source

Beacon Light: February 1959 [PDF]

open access: yes, 1959
Student Christmas Program Nurses Alumnae Association Meeting New Personnel Policies Sister Annora Leaves Hospital Sister Jameen New Hospital ...
St. Cloud Hospital
core   +1 more source

Home - About - Disclaimer - Privacy